Pittsburgh Compound B and the Postmortem Diagnosis of Alzheimer’s Disease

OBJECTIVE: Deposition of the amyloid-β (Aβ) peptide in neuritic plaques is a requirement for the diagnosis of Alzheimer’s disease (AD). Although the continued development of in vivo imaging agents such as Pittsburgh Compound B (PiB) is promising, the diagnosis of AD is still challenging. This can be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Niedowicz, Dana M., Beckett, Tina L., Matveev, Sergey, Weidner, Adam M., Baig, Irfan, Kryscio, Richard J., Mendiondo, Marta S., LeVine, Harry, Keller, Jeffrey N., Murphy, M. Paul
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490445/
https://ncbi.nlm.nih.gov/pubmed/23109151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados